Left main coronary artey disease: Is CABG still the gold standard?

Reviews in Cardiovascular Medicine

Volumn 6, Issue 4, 2005, Pages 187-193

  Ng, Martin K C ^a,b   Yeung, Alan C ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b ROYAL PRINCE ALFRED HOSPITAL   (Australia)

Author keywords

Coronary artery disease; Left main; Stenting

Indexed keywords

ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PACLITAXEL; RAPAMYCIN;

ATHERECTOMY; CLINICAL TRIAL; COMORBIDITY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; CORONARY ARTERY RECANALIZATION; CORONARY ARTERY THROMBOSIS; CORONARY STENT; DISEASE SEVERITY; DRUG ELUTING STENT; FOLLOW UP; HEART DEATH; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; IN-STENT RESTENOSIS; INTERMETHOD COMPARISON; LEFT CORONARY ARTERY; MORTALITY; OUTCOMES RESEARCH; PERCUTANEOUS CORONARY INTERVENTION; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PROGNOSIS; REOPERATION; REVIEW; RISK ASSESSMENT; STANDARD; STATISTICAL SIGNIFICANCE; SURGICAL RISK; SURVIVAL RATE; SURVIVAL TIME; TREATMENT CONTRAINDICATION; TREATMENT INDICATION; TREATMENT OUTCOME;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; BLOOD VESSEL PROSTHESIS IMPLANTATION; CORONARY ARTERIOSCLEROSIS; CORONARY ARTERY BYPASS; CORONARY STENOSIS; HUMANS; RANDOMIZED CONTROLLED TRIALS; STENTS;

EID: 31344469014     PISSN: 15306550     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (35)

1. Herrick J. Clinical features of sudden obstruction of the coronary arteries. JAMA. 1912;59: 2015-2020.
2. Conti CR, Selby JH, Christie LG, et al. Left main coronary artery stenosis: clinical spectrum pathophysiology and management. Prog Cardiovasc Dis. 1979;22:73-106.
3. Conley MJ, Ely RL, Kisslo J, et al. The prognostic spectrum of left main stenosis. Circulation. 1978;57:947-952.
4. Takaro T, Hultgren HN, Lipton MJ, Detre KM. The VA cooperative randomized study of surgery for coronary arterial occlusive disease: II. subgroup with significant left main lesions. Circulation. 1976;54:III-107-III-116.
5. Chaitman BR, Fisher LD, Bourassa MG, et al. Effect of coronary bypass surgery on survival patterns in subsets of patients with left main coronary artery disease: report of the Collaborative Study in Coronary Artery Surgery (CASS). Am J Cardiol. 1981;48:765-777.
6. Caracciolo EA, Davis KB, Sopko G, et al. Comparison of surgical and medical group survival in patients with left main coronary artery disease. Long-term CASS experience. Circulation. 1995;91:2325-2334.
7. European Coronary Surgery Study Group. Prospective randomized study of coronary artery bypass in stable angina pectoris. Lancet. 1980;2:491-495.
8. Cohen MV, Gorlin R. Main left coronary artery disease: clinical experience from 1964-1974. Circulation. 1975;52:275-285.
9. Talano JV, Scanlon PJ, Meadows WR, et al. Influence of surgery on survival in 145 patients with left main coronary artery disease. Circulation. 1975;52(2 Suppl):I105-I111.
10. Oberman A, Kouchoukos NT, Harrell RR, et al. Surgical versus medical treatment in disease of the left main coronary artery. Lancet. 1976;2: 591-594.
11. The Veterans Administration Coronary Artery Bypass Surgery Cooperative Study Group. Eleven-year survival in the Veterans Administration randomized trial of coronary bypass surgery for stable angina. N Engl J Med. 1984; 311:1333-1339.
12. European Coronary Surgery Study Group. Long-term results of a prospective randomized study of coronary artery bypass surgery in stable angina pectoris. Lancet. 1982;2:1173-1180.
13. Varnauskas E, for European Coronary Surgery Study Group. Twelve-year follow-up of survival in the randomized European Coronary Surgery Study. N Engl J Med. 1988;319:332-337.
14. Kennedy JW, Kaiser GC, Fisher LD, et al. Clinical and angiographic predictors of operative mortality from the Collaborative Study in Coronary Artery Surgery (CASS). Circulation. 1981;63:793-802.
15. Chaitman BR, Rogers W, Davis K, et al. Operative risk factors in patients with left main coronary artery disease. N Engl J Med. 1980;303:953-957.
16. Bourassa MG, Enjalbert M, Campeau L, Lesperance J. Progression of atherosclerosis in coronary arteries and bypass grafts: ten years later. Am J Cardiol. 1984;53:102C-107C.
17. Gruentzig AR. Transluminal dilatation of coronary artery stenosis. Lancet. 1978;1:263.
18. Gruentzig AR, Senning A, Siegenthaler WE. Nonoperative dilatation of coronary artery stenosis. N Engl J Med. 1979;301:61-67.
19. O'Keefe JHJ, Hartzler GO, Rutherford BD, et al. Left main coronary angioplasty: early and late results of 127 acute and elective procedures. Am J Cardiol. 1989;64:144-147.
20. Tommaso CL, Vogel JHK, Vogel RA. Coronary angioplasty in high risk patients with left main coronary stenosis: Results from the National Registry of Elective Supported Angioplasty. Cathet Cardiovasc Diagn. 1992;25:169-173.
21. Serruys PW, de Jaegere P, Kiemeneij F, et al. A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. Benestent Study Group. N Engl J Med. 1994;331:489-495.
22. Park SJ, Hong MK, Lee CW, et al. Elective stenting of unprotected left main coronary artery stenosis. Effect of debulking before stenting and intravascular ultrasound guidance. J Am Coll Cardiol. 2001;38:1054-1060.
23. Ellis SG, Tamai H, Nobuyoshi M, et al. Contemporary percutaneous treatment of unprotected left main coronary stenoses initial results from a multicenter registry analysis 1994-1996. Circulation. 1997;96:3867-3872.
24. Park SJ, Park SW, Hong MK, et al. Stenting of unprotected left main coronary artery stenoses: immediate and late outcomes. J Am Coll Cardiol. 1998;31:37-41.
25. Silvestri M, Barragan P, Sainsous J, et al. Unprotected left main coronary artery stenting: immediate and medium-term outcomes of 140 elective procedures. J Am Coll Cardiol. 2000; 35:1543-1550.
26. Black A, Cortina R, Bossi I, et al. Unprotected left main coronary artery stenting: correlates of midterm survival and impact of patient selection. J Am Coll Cardiol. 2001;37:832-838.
27. Takagi T, Stankovic G, Finci L, et al. Results and long-term predictors of adverse clinical events after elective percutaneous interventions on unprotected left main coronary artery. Circulation. 2002;106:698-702.
28. Tan WA, Tamai H, Park SJ, et al. Long-term clinical outcomes after unprotected left main trunk percutaneous revascularization in 279 patients. Circulation. 2001;104:1609-1614.
29. Morice MC, Serruys PW, Sousa JE, et al. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med. 2002;346:1773-1780.
30. Stone GW, Ellis SG, Cox DA, et al. A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease. N Engl J Med. 2004; 350:221-231.
31. Park SJ, Kim YH, Lee BK, et al. Sirolimus-eluting stent implantation for unprotected left main coronary artery stenosis: comparison with bare metal stent implantation. J Am Coll Cardiol. 2005;45:351-356.
32. Valgimigli M, van Mieghem CA, Ong AT, et al. Short- and long-term clinical outcome after drug-eluting stent implantation for the percutaneous treatment of left main coronary artery disease: Insights from the Rapamycin-Eluting and Taxus Stent Evaluated At Rotterdam Cardiology Hospital registries (RESEARCH and T-SEARCH). Circulation. 2005;22:1383-1389.
33. Chieffo A, Stankovic G, Bonizzoni E, et al. Early and mid-term results of drug-eluting stent implantation in unprotected left main. Circulation. 2005;111:791-795.
34. Ellis SG, Hill CM, Lytle BW. Spectrum of surgical risk for left main coronary stenoses: benchmark for potentially competing percutaneous therapies. Am Heart J. 1998;135 (2 Pt 1):335-338.
35. d'Allonnes FR, Corbineau H, Le Breton H, et al. Isolated left main coronary artery stenosis: long term follow up in 106 patients after surgery. Heart. 2002;87:544-548.